Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transgenic Cotton (Gossypium hirsutum L.) to Combat Weed Vagaries: Utility of an Apical Meristem-Targeted in planta Transformation Strategy to Introgress a Modified CP4-EPSPS Gene for Glyphosate Tolerance.
Karthik K, Nandiganti M, Thangaraj A, Singh S, Mishra P, Rathinam M, Sharma M, Singh NK, Dash PK, Sreevathsa R. Karthik K, et al. Among authors: sharma m. Front Plant Sci. 2020 Jul 7;11:768. doi: 10.3389/fpls.2020.00768. eCollection 2020. Front Plant Sci. 2020. PMID: 32733492 Free PMC article.
Targeting the endocannabinoid system in diabesity: Fact or fiction?
Deeba F, Kumar A, Mukherjee M, Sharma AK, Sharma M. Deeba F, et al. Among authors: sharma ak, sharma m. Drug Discov Today. 2021 Jul;26(7):1750-1758. doi: 10.1016/j.drudis.2021.03.022. Epub 2021 Mar 27. Drug Discov Today. 2021. PMID: 33781949 Review.
Synthesis, molecular docking, and pharmacological evaluation of 5-(4-(2-(5-ethyl pyridine-2-yl) ethoxy) benzyl)-3-(phenylsulfonyl) thiazolidine-2, 4-dione against HFD-induced diabesity via interaction with the CB1 receptor.
Deeba F, Shahar Yar M, Rafi Haidar M, Sharma AK, Sharma M. Deeba F, et al. Among authors: sharma ak, sharma m. Iran J Basic Med Sci. 2022 Aug;25(8):1028-1036. doi: 10.22038/IJBMS.2022.65649.14443. Iran J Basic Med Sci. 2022. PMID: 36159331 Free PMC article.
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Gelderblom H, Bhadri V, Stacchiotti S, Bauer S, Wagner AJ, van de Sande M, Bernthal NM, López Pousa A, Razak AA, Italiano A, Ahmed M, Le Cesne A, Tinoco G, Boye K, Martín-Broto J, Palmerini E, Tafuto S, Pratap S, Powers BC, Reichardt P, Casado Herráez A, Rutkowski P, Tait C, Zarins F, Harrow B, Sharma MG, Ruiz-Soto R, Sherman ML, Blay JY, Tap WD; MOTION investigators. Gelderblom H, et al. Among authors: sharma mg. Lancet. 2024 May 31:S0140-6736(24)00885-7. doi: 10.1016/S0140-6736(24)00885-7. Online ahead of print. Lancet. 2024. PMID: 38843860
9,629 results